GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outsmart tough lymphoma
Disease control Recruiting nowThis study tests whether combining two drugs, pirtobrutinib and mosunetuzumab, can better treat follicular lymphoma that has come back or not responded to prior therapy. About 22 adults with grade 1-3a lymphoma will receive the combination. The goal is to increase the chance of c…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 04:28 UTC
-
New Low-Dose drug shows promise for controlling Slow-Growing lymphoma
Disease control Recruiting nowThis study tests a lower dose of the drug mosunetuzumab in 20 adults with slow-growing B-cell lymphoma that has not been treated before. The goal is to see if it can shrink tumors and control the disease while being safe. Participants will receive the drug and be monitored for si…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 04:27 UTC